For example, SCN1A mutation-related epilepsy had a disease onset of several months, its clinical presentation was mainly DS, and few patients showed febrile seizures; while sodium channel blockers generally caused symptoms to worsen. This evidence concerns the gene SCN1A and Dravet syndrome.